ANTIMICROBIAL
TECHNOLOGY - VIRTUAL
SYMPOSIUM hosted by DENTAL CE ACADEMY
SESSION 4 OF 6: THE NEW DENTAL ANTIBIOTIC
GUIDANCE
January 6, 2023: 12 - 1:30 pm PT | 3 - 4:30 pm
ET
[ENTIRE SYMPOSIUM AGENDA CAN BE FOUND HERE] *Registrants
will receive access to the replay.
Hosted by Dental CE
Academy, an AGD PACE nationally approved provider
#405345
COST: No charge
1.5 CEU: Electronically mediated. Live
interactive webinar
AGD PACE SUBJECT CODE: 016
Pharmacotherapeutics
SPEAKER: Dr. Debra Goff, Pharm.D., FIDSA FCCP.
Infectious Diseases Specialist. Global Antibiotic Stewardship. The
Ohio State University Wexner Medical Center. Professor of Pharmacy
Practice, The Ohio State University College of Pharmacy.
SPONSOR: Perio Protect
DESCRIPTION: This program aims to discuss new
dental literature on the prophylactic and therapeutic use of
antibiotics to guide dentists to make appropriate antibiotic
decisions.
EDUCATIONAL OBJECTIVES:
1.Review new guidance on the use of clindamycin and
quinolones
2. Discuss 5 antibiotic practice changes dentists should
make
3. Describe the prevalence of antibiotic resistance and its
impact on dental patients
4. Analyze new studies that evaluate dental antibiotic use for
prophylaxis and treatment
5. Define the role of dentists in dental antibiotic stewardship
based on the American Dental Association (ADA) endorsement of the
Centers for Disease Control and Prevention (CDC) recommendations
for dentists.
ABSTRACT: Dentists prescribe approximately 10%
of all outpatient antibiotic prescriptions in the United States
(US), writing more than 25.7 million prescriptions per year.
Dentists not only prescribe a significant proportion of
antibiotics, but dentists are also the top prescribers of
clindamycin in the United States, which is the most common
antibiotic to cause Clostridium difficile infections. Over
80% of antibiotics prescribed by dentists for prophylaxis have been
found to be unnecessary. Dental antibiotic prescriptions for
therapeutic use are frequently written for durations of 7, 10, and
14 days with little data to support the prolong durations.
Conflicting scientific evidence, lack of evidence, fear of lawsuits
and lack of new information on antibiotic risks are factors that
contribute to inappropriate antibiotic use. The overuse and misuse
of antibiotics in dentistry contributes to antibiotic resistance,
costs and patient harm.
BIO: Dr. Goff is an infectious diseases
clinical pharmacist and the founding member o the Antibiotic
Stewardship Program (ASP) at The Ohio State University Wexner
Medical Center (OSUWMC). Dr. Goff collaborated with the CDC on the
first Dental Antibiotic Stewardship iniitiative involving private
practice dentists and orthopedic surgeons in June 2018 Columbus OH.
They examined one of the most challenging topics in dentistry, the
use of dental antibiotic prophylaxis in joint implant patients.
Thirty local dentists and orthopedic surgeons participated in their
workshop. She conducted the first US study with private practice
dentists to evaluate their antibiotic prescribing and identify
appropriate use. She has experience working with dentists and
listening to the educational needs of dentists related to the
appropriate use of antibiotics. She founded the OSU-South Africa
Train-the-Trainer Antibiotic Stewardship Program in 2012 and
received the 2019 Distinguished International Outreach and
Engagement Award for her work in South Africa. Dr. Goff is one of
twenty-five global experts selected by the World Health
Organization (WHO) to implement antibiotic stewardship programs in
low-middle income countries. She lectures nationally and
internationally and has over 110 peer-reviewed publications and 50
grants.
